Oxidative imbalance in Alzheimer's disease

被引:120
作者
Zhu, XW [1 ]
Lee, HG
Casadesus, G
Avila, J
Drew, K
Perry, G
Smith, MA
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[2] Univ Autonoma Madrid, CSIC, Ctr Mol Biol, Fac Ciencias, E-28049 Madrid, Spain
[3] Univ Alaska, Dept Chem & Biochem, Fairbanks, AK 99701 USA
[4] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99701 USA
关键词
oxidative stress; mitochondria; metal ion; hydrogen peroxide; A beta; tau;
D O I
10.1385/MN:31:1-3:205
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Oxidative stress is a striking feature of susceptible neurons in the Alzheimer's disease brain. Importantly, because oxidative stress is an early event in Alzheimer's disease, proximal to the development of hallmark pathologies, it likely plays an important role in the pathogenesis of the disease. Investigations into the cause of such oxidative stress show that interactions between abnormal mitochondria and disturbed metal metabolism are, at least in part, responsible for cytoplasmic oxidative damage observed in these susceptible neurons, which could ultimately lead to their demise. Oxidative stress not only temporally precedes the pathological lesions of the disease but could also contribute to their formation, which, in turn, could provide some protective mechanism to reduce oxidative stress and ensure that neurons do not rapidly succumb to oxidative insults. In this review, we present the evidence for oxidative stress in Alzheimer's disease and its likely sources and consequence in relation to other pathological changes.
引用
收藏
页码:205 / 217
页数:13
相关论文
共 138 条
  • [61] Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease
    Matsubara, E
    Bryant-Thomas, T
    Quinto, JP
    Henry, TL
    Poeggeler, B
    Herbert, D
    Cruz-Sanchez, F
    Chyan, YJ
    Smith, MA
    Perry, G
    Shoji, M
    Abe, K
    Leone, A
    Grundke-Ikbal, I
    Wilson, GL
    Ghiso, J
    Williams, C
    Refolo, LM
    Pappolla, MA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 (05) : 1101 - 1108
  • [62] 4-hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau
    Mattson, MP
    Fu, WM
    Waeg, G
    Uchida, K
    [J]. NEUROREPORT, 1997, 8 (9-10) : 2275 - 2281
  • [63] A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
    Maurer, I
    Zierz, S
    Möller, HJ
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 455 - 462
  • [64] Oxidative damage to DNA in lymphocytes from AD patients
    Mecocci, P
    Polidori, MC
    Ingegni, T
    Cherubini, A
    Chionne, F
    Cecchetti, R
    Senin, U
    [J]. NEUROLOGY, 1998, 51 (04) : 1014 - 1017
  • [65] Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease
    Mecocci, P
    Polidori, MC
    Cherubini, A
    Ingegni, T
    Mattioli, P
    Catani, M
    Rinaldi, P
    Cecchetti, R
    Stahl, W
    Senin, U
    Beal, MF
    [J]. ARCHIVES OF NEUROLOGY, 2002, 59 (05) : 794 - 798
  • [66] Oxidative stress induces intracellular accumulation of amyloid β-protein (Aβ) in human neuroblastoma cells
    Misonou, H
    Morishima-Kawashima, M
    Ihara, Y
    [J]. BIOCHEMISTRY, 2000, 39 (23) : 6951 - 6959
  • [67] Montine TJ, 1996, AM J PATHOL, V148, P89
  • [68] The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients
    Montine, TJ
    Markesbery, WR
    Zackert, W
    Sanchez, SC
    Roberts, LJ
    Morrow, JD
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (03) : 863 - 868
  • [69] Elevated CSF prostaglandin E2 levels in patients with probable AD
    Montine, TJ
    Sidell, KR
    Crews, BC
    Markesbery, WR
    Marnett, LJ
    Roberts, LJ
    Morrow, JD
    [J]. NEUROLOGY, 1999, 53 (07) : 1495 - 1498
  • [70] Increased CSF F2-isoprostane concentration in probable AD
    Montine, TJ
    Beal, MF
    Cudkowicz, ME
    O'Donnell, H
    Margolin, RA
    McFarland, L
    Bachrach, AF
    Zackert, WE
    Roberts, LJ
    Morrow, JD
    [J]. NEUROLOGY, 1999, 52 (03) : 562 - 565